"Higo Golden Opportunity", duplication compensation plan, "reverse aging" supplements & health-claim warnings · 2026 edition
HIGO combines three recognised warning signs: unproven, impermissible disease claims ("reverse aging 8–34 years", "keep your body free of cancer", "ward off Alzheimer's") that no supplement may lawfully make; a misrepresented "NIH listing" that is only a public label database, not an endorsement; and a recruitment-driven "duplication" pay plan with multi-million-dollar hypothetical earnings and no average-income disclosure. Reaching the top tier shown requires roughly 87,380 recruits in one downline, impossible for most members, who typically lose money. Verify everything independently and treat health claims with a doctor's input. This is information, not personalised financial or medical advice.
HIGO, marketed as "Higo Golden Opportunity" and "HIGO Dragon Capital Corp", presents itself as a "US-funded multinational" cross-border e-commerce and health company "built by DRGV Capital of the United States", fronted in the deck by a named individual (Toh Seng Hock) with MNC and venture-capital credentials. It claims over 400,000 active members, a management and "scientist" team, offices/factories across Malaysia, Vietnam, Korea, Canada, Japan and Macau, and a Singapore entity, HIGO 368 PTE LTD.
Behind the corporate framing, the actual offer is a supplement sold through a multi-level compensation plan. The names, slogans and prestige affiliations in the deck are assertions; little of it is independently verified, and a marketing slide is not confirmation of any institution's endorsement or involvement. Treat the corporate claims as things to check on company registries, not as established facts.
HIGO's product line is built around GnAKG (alpha-ketoglutarate), with sister products GnCell, GnHormone and GnBrain, sold as "anti-aging films" (60 tablets/bottle). The marketing claims are extreme: "easily reverse age 8.5–34 years", "regulates stem cell rejuvenation", "keep your body free of cancer", "ward off Alzheimer's", "prevent neurological diseases", and "restore the reproductive system to peak condition".
These are disease prevention and treatment claims. In the US, EU and most jurisdictions a dietary supplement is not permitted to claim to prevent, treat or cure disease, and the deck shows no clinical-trial evidence for any of them. The only third-party document is an SGS report (Aug 2025), but that is a contaminant and microbiology safety screen (heavy metals "not detected", microbes within spec). It says nothing about whether the product does what is claimed; it is not evidence of efficacy. AKG is a real, studied compound, but human evidence for dramatic "age reversal" is very limited, so the headline numbers warrant strong scepticism and a doctor's input.
One slide overlays a graphic on the real NIH website and claims HIGO is "Listed in the Official Database of the U.S. National Institutes of Health (NIH)", reframed as "Government-Endorsed Certification" signifying "the highest standards of quality and safety", and invites you to verify a product ID at dsld.od.nih.gov.
That database is the NIH Dietary Supplement Label Database, a public catalogue of labels submitted by manufacturers. Being listed in it is not an NIH endorsement, certification, approval, or any statement about quality, safety or efficacy. Presenting a label-database entry as a "government-endorsed certification" misrepresents what it is. Likewise, the "FDA" badge means "FDA registered", which is not "FDA approved", the FDA does not approve dietary supplements before sale. The other badges (cGMP, Non-GMO, HALAL, NSF, "Made in USA") are worth verifying individually rather than taking at face value.
This section documents how the HIGO plan, its compensation structure, is presented in the company deck, so readers can understand the mechanics, not as an invitation to join. The defining feature is that income rises with recruitment and with the product packs a downline buys, which is the signature of multi-level marketing rather than ordinary retail.
You join by purchasing GnAKG packs; the pack you buy sets your starting rank and commission rates:
| Identity | Join condition | Direct promo | Team bonus |
|---|---|---|---|
| Common Agent | 1 bottle GnAKG · $135 | 15% | 10% |
| Senior Agent | 3 bottles · $405 | 30% | 15% |
| Provincial agency | 5 bottles · $675 | 40% | 20% |
Income comes from two streams (1 bottle = $135 / 100 PV; 5 bottles = $675 / 500 PV):
Worked examples from the deck: sponsor 2 people on 5-bottle packs → $372.5; sponsor 4 people → $765, framed as "getting back your capital" (i.e. the buy-in is recouped only by recruiting).
A nine-tier rank ladder scales required "community PV" and the weekly payout cap:
| Rank | Community PV | Weekly cap |
|---|---|---|
| Agent | N/A | $200 |
| 1 Star | 500 | $300 |
| 2 Star | 2,500 | $1,000 |
| 3 Star | 5,000 | $2,000 |
| 1 Diamond | 15,000 | $5,000 |
| 2 Diamond | 25,000 | $10,000 |
| 3 Diamond | 50,000 | $20,000 |
| 1 Black Diamond | 150,000 | $50,000 |
| 2 Black Diamond | 250,000 | $80,000 |
| 3 Black Diamond | 500,000 | $100,000 |
The plan's engine is duplication: you recruit 4, they each recruit 4, repeating. The weekly team bonus is paid as (people at that level) × $76.5:
| Duplication level | New recruits | Team bonus | Rank reached |
|---|---|---|---|
| 1st (sponsor 4) | 4 | $765 total | "capital back" |
| 2nd | 16 | $612 | N/A |
| 3rd | 64 | $2,448 | N/A |
| 4th | 256 | $9,792 | Diamond |
| 5th | 1,024 | $39,168 | 2 Diamond |
| 6th | 4,096 | $156,672 | 3 Diamond |
| 7th | 16,384 | $626,688 | Black Diamond |
| 8th | 65,536 | $2,506,752 | 3 Black Diamond |
Reaching the top figure requires 4 + 16 + 64 + … + 65,536 = 87,380 people in a single downline. The deck also advertises ceilings of "$100k/week" and "$2,500–$100,000/week" for "400+ Diamonds", illustrative maximums, not typical earnings, with no average-income disclosure.
The deck states a 15% platform service fee, a 5% withdrawal handling fee and a 3% "mutual transfer hedging" deduction; commission is in US dollars over four-week cycles, withdrawn to a bank card or as "U" (USDT crypto). These deductions meaningfully reduce what reaches a participant, and crypto payout rails are worth scrutinising for reliability.
Every participant is told to recruit 4 and get each of them to recruit 4. That ×4 chain is self-limiting: each added level multiplies the people required, and the top tier shown needs ~87,380 recruits beneath a single member. It is mathematically impossible for the population at large to each find four more, so the structure mathematically guarantees that the large majority, the later joiners, cannot recruit enough to recover their buy-in.
Because rewards come mainly from recruitment and from participants' own pack purchases rather than genuine retail sales to non-participants, the plan carries the hallmarks regulators use to identify a pyramid scheme. The unproven product claims and the "capital back by sponsoring 4" framing reinforce that the real engine is enrolment, not retail demand.
This block replaces a customer-reviews section. MLMCompanyHub does not publish invented reviews or a star score for a scheme in this risk band.
Health-claims context. Dietary supplements may not lawfully claim to prevent, treat or cure disease. Claims to "reverse aging", keep the body "free of cancer" or "ward off Alzheimer's" are exactly the kind regulators act against, and an SGS contaminant screen is not evidence that any such claim is true. Make health decisions with a qualified doctor, not a marketing deck.
Regulatory context. A plan where income depends mainly on recruiting others and on participants' own purchases is treated as a pyramid/money-circulation scheme in many jurisdictions. In India that engages the Prize Chits and Money Circulation Schemes (Banning) Act, 1978, the Consumer Protection (Direct Selling) Rules, 2021 (which prohibit pyramid and money-circulation schemes), and the BUDS Act, 2019 for deposit-like return promises; the US FTC pursues the same structure, and the FDA/FTC act on illegal supplement health claims. Promoting or enrolling others can carry personal legal liability, not just financial loss.
MLMCompanyHub is not a regulator and makes no legal determination about HIGO. This page reports the company's own deck and applies general, publicly available regulator guidance and arithmetic so readers can verify each point. Before parting with money, verify the company on the relevant registries, ask for an average-income disclosure, and check your regulator's warnings on MLM/pyramid schemes and supplement claims. To report suspected fraud in India, use cybercrime.gov.in / 1930.
HIGO is a supplement MLM selling GnAKG "anti-aging" products. You join by buying product packs (from $135 for one bottle up to $675 for five) and earn through a referral bonus (~$30.6/bottle, instant), a weekly team bonus (~$15.3/bottle), and an agent/Diamond rank ladder with weekly caps from $200 up to $100,000. It runs on "duplication", recruit 4, who each recruit 4, so income depends mainly on recruitment rather than retail sales.
HIGO shows several recognised warning signs: a recruitment-driven "duplication" pay plan, very large hypothetical earnings ($100k/week, millions) with no average-income disclosure, unproven and impermissible disease claims for a supplement, and a misrepresented "NIH listing". MLMCompanyHub does not endorse it and rates it very high risk. Verify the company and its claims independently before committing money or your network.
There's no evidence in the deck to support that. "Reverse aging 8.5–34 years", "keep your body free of cancer" and "ward off Alzheimer's" are disease prevention/treatment claims that supplements cannot lawfully make, and no clinical-trial data is shown. The only third-party document is an SGS contaminant/microbiology safety screen, which says nothing about efficacy. AKG is a real compound, but human evidence for dramatic age reversal is very limited.
No. The "NIH listing" refers to the NIH Dietary Supplement Label Database (dsld.od.nih.gov), a public catalogue of manufacturer-submitted labels. Being listed is not an endorsement, certification, approval, or any statement about quality, safety or efficacy. And "FDA registered" is not "FDA approved", the FDA does not approve dietary supplements before sale.
Earnings come mainly from recruiting people who buy product packs and getting them to recruit more ("duplication", ×4 each level). The deck's projections grow earnings purely as headcount doubles, not from retail sales, and tell you to "get back your capital by sponsoring 4 people". That structure has the hallmarks regulators use to identify a pyramid scheme, and the top tier shown needs ~87,380 people in one downline, impossible for most participants.
Yes. The buy-in is recoverable only by recruiting, withdrawals carry sizeable deductions (15% + 5% + 3%) and can be paid in USDT crypto, and the duplication math means the large majority of later joiners cannot recruit enough to profit. In recruitment-driven structures most participants typically lose money.
Pramendraa Singh researches and analyses direct-selling and network-marketing companies for MLMCompanyHub. He writes business-plan and compensation-plan breakdowns, company profiles, and product and industry research, with a focus on well-researched, unbiased, easy-to-understand content that helps readers and entrepreneurs understand how MLM companies and their pay plans actually work.